Gene therapy is claimed to be a major breakthrough in the field of progressive living and anti- aging. BioViva USA Inc. is a company founded by Elizabeth Parrish with ambitious plans to make the healthy longevity technology available to all.
Elizabeth Parrish is claimed to be the first woman to successfully use gene therapy to slow down aging.
Parrish explains that BioViva uses a unique approach towards tackling diseases. By a way of focusing on anti- aging through gene therapies, it aims at resolving aging-related diseases. Primarily because biological aging is the root cause for many of the diseases one suffer in their old days.
BioViva is looking to take gene therapy forward by mainly targeting Telomeres. Telomeres are a kind of protective caps present on each DNA strand called chromosomes, which house our genomes.
These telomeres reduce in size with each cell division. Once it reaches a certain point the cells either stop dividing or die. This basically results in aging and the onset of diseases that aging has to offer.
In September 2015, Parrish has received two of her own company’s experimental gene therapies. While the first treatment aimed at protecting loss of muscle mass with age, the second one focused on reducing stem cell depletion which is the causation of numerous age-related diseases and infirmities.
Parrish has also received a dose of virus containing genetic material that produces telomerase. It is a protein that extends telomeres.
Tests taken prior the treatment depicted that Parrish’s telomeres were unusually short for her age. Thereby leaving her vulnerable to age-associated diseases much earlier in life.
In March 2016 through tests conducted post- therapy, have revealed that her telomeres of white blood cells have lengthened by approximately 20 years, from 6.71kb to 7.33kb. It denotes that her cells now are much younger and healthy.
Brussels-based non-profit HEALES (HEalthy Life Extension Company), and the Biogerontology Research Foundation, a UK-based charity committed to combating age-related diseases have verified these findings.
Given all the data is accurate, it is the world’s first example of telomere lengthening by using gene therapy.